Overview

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy (based on the pharmacokinetic profile of testosterone) and safety of TBS-1 in the treatment of hypogonadal men
Phase:
Phase 3
Details
Lead Sponsor:
Acerus Pharmaceuticals Corporation
Trimel Biopharma SRL
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate